AskTheDate.com
Back to calendar

Metagenomi Therapeutics, Inc. (MGX) Earnings

MGX reports earnings on Wednesday, August 19, 2026

earnings report
August 19, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.55
Actual EPS: $-0.61
EPS surprise: -10.23%
Company overview
Market Cap$45.6M
PriceUSD 1.21
EPS (TTM)-2.29
52-week high3.95
52-week low1.13
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees119